Chlorine in PDB 5hi2: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib

Enzymatic activity of Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib

All present enzymatic activity of Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib:
2.7.11.1;

Protein crystallography data

The structure of Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib, PDB code: 5hi2 was solved by D.M.Whalen, S.A.Foster, A.Ozen, M.Wongchenko, J.Yin, G.Schaefer, J.Mayfield, J.Chmielecki, P.Stephens, L.Albacker, Y.Yan, K.Song, G.Hatzivassiliou, C.Eigenbrot, C.Yu, A.S.Shaw, G.Manning, N.J.Skelton, S.G.Hymowitz, S.Malek, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.56 / 2.51
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 49.625, 114.920, 101.544, 90.00, 90.00, 90.00
R / Rfree (%) 18.5 / 23.7

Other elements in 5hi2:

The structure of Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib also contains other interesting chemical elements:

Fluorine (F) 3 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib (pdb code 5hi2). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib, PDB code: 5hi2:

Chlorine binding site 1 out of 1 in 5hi2

Go back to Chlorine Binding Sites List in 5hi2
Chlorine binding site 1 out of 1 in the Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl801

b:37.6
occ:1.00
 CL11 A:BAX801 0.0 37.6 1.0
C5 A:BAX801 1.7 18.4 1.0
C6 A:BAX801 2.7 19.3 1.0
C4 A:BAX801 2.7 14.6 1.0
F10 A:BAX801 2.9 26.5 1.0
C7 A:BAX801 3.0 27.3 1.0
F9 A:BAX801 3.0 28.1 1.0
CG1 A:VAL504 3.7 36.9 1.0
CG2 A:ILE572 3.9 27.8 1.0
C1 A:BAX801 3.9 23.2 1.0
C3 A:BAX801 4.0 16.4 1.0
CD2 A:HIS574 4.3 21.7 1.0
F8 A:BAX801 4.4 34.0 1.0
CA A:HIS574 4.4 24.7 1.0
C2 A:BAX801 4.4 18.6 1.0
CG A:HIS574 4.6 22.4 1.0
CD1 A:LEU567 4.7 22.3 1.0
O A:HIS574 4.7 26.9 1.0
CD2 A:LEU567 4.8 24.6 1.0
NE2 A:HIS574 4.8 23.1 1.0
O A:ILE573 4.9 28.3 1.0
CB A:VAL504 4.9 37.3 1.0
CB A:HIS574 4.9 22.9 1.0

Reference:

S.A.Foster, D.M.Whalen, A.Ozen, M.J.Wongchenko, J.Yin, I.Yen, G.Schaefer, J.D.Mayfield, J.Chmielecki, P.J.Stephens, L.A.Albacker, Y.Yan, K.Song, G.Hatzivassiliou, C.Eigenbrot, C.Yu, A.S.Shaw, G.Manning, N.J.Skelton, S.G.Hymowitz, S.Malek. Activation Mechanism of Oncogenic Deletion Mutations in Braf, Egfr, and HER2. Cancer Cell V. 29 477 2016.
ISSN: ISSN 1535-6108
PubMed: 26996308
DOI: 10.1016/J.CCELL.2016.02.010
Page generated: Sat Dec 12 11:48:32 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy